These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9340191)

  • 21. Influence of the parathyroid glands on bone metabolism.
    Malluche HH; Koszewski N; Monier-Faugere MC; Williams JP; Mawad H
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():23-33. PubMed ID: 16884395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parathyroid hormone - a bone anabolic and catabolic agent.
    Poole KE; Reeve J
    Curr Opin Pharmacol; 2005 Dec; 5(6):612-7. PubMed ID: 16181808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
    Chlebna-Sokol D; Rusinska A
    Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential of parathyroid hormone as a therapy for osteoporosis.
    Rubin MR; Bilezikian JP
    Int J Fertil Womens Med; 2002; 47(3):103-15. PubMed ID: 12081255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormonal regulation of bone metabolism].
    Gera I
    Fogorv Sz; 1993 Apr; 86(4):107-20. PubMed ID: 8243730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Continuous remodeling of the skeleton. Growth factors and cytokines direct the activity].
    Ljunggren O; Ljunghall S; Lerner U
    Lakartidningen; 1995 May; 92(20):2094-6, 2099-100. PubMed ID: 7760596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigational anabolic therapies for osteoporosis.
    Trivedi R; Goswami R; Chattopadhyay N
    Expert Opin Investig Drugs; 2010 Aug; 19(8):995-1005. PubMed ID: 20629616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Growth hormone and its significance beyond growth. Current aspects of the effects of this model anabolic hormone].
    Girard J
    Schweiz Rundsch Med Prax; 1993 Aug; 82(32):845-50. PubMed ID: 8372278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bone remodelling and its regulators].
    Yoshikawa H; Takaoka K
    Nihon Rinsho; 1994 Sep; 52(9):2262-7. PubMed ID: 7967065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Growth factors and cytokines in bone metabolism].
    Nagasaka Y; Kaneko T
    Nihon Rinsho; 1994 Sep; 52(9):2301-4. PubMed ID: 7967072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal and hormonal effects of magnesium deficiency.
    Rude RK; Singer FR; Gruber HE
    J Am Coll Nutr; 2009 Apr; 28(2):131-41. PubMed ID: 19828898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between magnesium and calciotropic hormones.
    Zofková I; Kancheva RL
    Magnes Res; 1995 Mar; 8(1):77-84. PubMed ID: 7669510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The physiology of the circadian rhythm of parathyroid hormone and its potential as a treatment for osteoporosis.
    Fraser WD; Ahmad AM; Vora JP
    Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):437-44. PubMed ID: 15199294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of impaired growth: effect of steroids on bone and cartilage.
    Olney RC
    Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
    Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
    Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone and bone.
    Bouillon R
    Horm Res; 1991; 36 Suppl 1():49-55. PubMed ID: 1806485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Growth hormone and bone metabolism].
    Manten JW; Verhaar HJ; Duursma SA
    Ned Tijdschr Geneeskd; 1996 May; 140(20):1064-8. PubMed ID: 8692323
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.
    Zofková I
    Physiol Res; 2003; 52(6):657-79. PubMed ID: 14640888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolism and immunology of bone.
    Watrous DA; Andrews BS
    Semin Arthritis Rheum; 1989 Aug; 19(1):45-65. PubMed ID: 2672341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis.
    Widler L
    Future Med Chem; 2011 Apr; 3(5):535-47. PubMed ID: 21526895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.